# Clinical Trial of C-Wave™ Peripheral Lithoclasty System Catheter System

Study · id `cardio:ct-nct05435716` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05435716](<https://clinicaltrials.gov/study/NCT05435716>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT05435716

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

## Technical summary

Registry record NCT05435716. Randomized; single masking; primary purpose treatment. Start 2021-08-05 (actual); primary completion 2023-09-08 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 120 participants (planned count; ClinicalTrials.gov record NCT05435716, source copy `cardio:ctgov-nct05435716-2022-09-22`, retrieved 2026-10-31)
- Started: 2021-08-05 (actual) (ClinicalTrials.gov record NCT05435716, source copy `cardio:ctgov-nct05435716-2022-09-22`, retrieved 2026-10-31)
- Primary completion: 2023-09-08 (anticipated) (ClinicalTrials.gov record NCT05435716, source copy `cardio:ctgov-nct05435716-2022-09-22`, retrieved 2026-10-31)
- Completion: 2023-09-08 (anticipated) (ClinicalTrials.gov record NCT05435716, source copy `cardio:ctgov-nct05435716-2022-09-22`, retrieved 2026-10-31)
- Countries: China (ClinicalTrials.gov record NCT05435716, source copy `cardio:ctgov-nct05435716-2022-09-22`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05435716-2022-09-22`, retrieved 2026-10-31)

## The registry's words

- Brief title: Clinical Trial of C-Wave™ Peripheral Lithoclasty System Catheter System
- Condition: Peripheral Arterial Disease
- Intervention (Device): C-wave™ peripheral seismic waveguide system
- Intervention (Device): Peripheral vascular balloon dilatation catheter (PTA)
- Lead sponsor: Suzhou Zhonghui Medical Technology Co., Ltd.
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)

## Provenance

Content hash: d3db604baa65902ccf684ad0d143f6be1c6f64286120967ff9493e28283960cb
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
